Vest Financial LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.6% during the second quarter, HoldingsChannel.com reports. The fund owned 414,609 shares of the company’s stock after selling 24,766 shares during the quarter. Cardinal Health accounts for about 1.0% of Vest Financial LLC’s holdings, making the stock its 14th largest position. Vest Financial LLC’s holdings in Cardinal Health were worth $69,654,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. bought a new stake in Cardinal Health in the first quarter valued at $26,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the period. GW&K Investment Management LLC grew its position in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after acquiring an additional 144 shares during the period. Garde Capital Inc. bought a new stake in Cardinal Health in the first quarter valued at $52,000. Finally, Zions Bancorporation National Association UT bought a new stake in Cardinal Health in the first quarter valued at $52,000. 87.17% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on CAH. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Leerink Partners increased their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Finally, Argus set a $189.00 price target on shares of Cardinal Health in a research report on Friday, August 22nd. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $166.00.
Insiders Place Their Bets
In related news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last 90 days. Corporate insiders own 0.12% of the company’s stock.
Cardinal Health Stock Down 0.2%
Shares of NYSE CAH opened at $156.86 on Monday. The firm’s 50-day simple moving average is $152.09 and its 200 day simple moving average is $151.31. The company has a market cap of $37.27 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- 3 Fintech Stocks With Good 2021 Prospects
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What is the Nikkei 225 index?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Why Are These Companies Considered Blue Chips?
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.